<--- Back to Details
First PageDocument Content
Cancer screening / Lung cancer / Prostate cancer / Prostate-specific antigen / Management of prostate cancer / Prostate / High-grade prostatic intraepithelial neoplasia / Benign prostatic hyperplasia / Prostatic acid phosphatase / Medicine / Oncology / Tumor markers
Date: 2015-02-25 08:39:41
Cancer screening
Lung cancer
Prostate cancer
Prostate-specific antigen
Management of prostate cancer
Prostate
High-grade prostatic intraepithelial neoplasia
Benign prostatic hyperplasia
Prostatic acid phosphatase
Medicine
Oncology
Tumor markers

pg:21

Add to Reading List

Source URL: www.iarc.fr

Download Document from Source Website

File Size: 1,61 MB

Share Document on Facebook

Similar Documents

Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

DocID: 1vjEy - View Document

RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

DocID: 1vfqs - View Document

Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth.

DocID: 1v3MR - View Document

Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital

DocID: 1v06s - View Document

Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath

DocID: 1uZ8r - View Document